Recida Therapeutics

Recida Therapeutics is a biotechnology company focused on developing innovative antibiotic drugs to combat serious infections caused by antibiotic-resistant bacteria. The company's primary aim is to create novel-class antibiotics that specifically target multi-drug resistant gram-negative bacteria, which pose significant health risks to patients. By addressing the growing challenge of antibiotic resistance, Recida Therapeutics seeks to provide effective therapeutic options for individuals facing potentially life-threatening infections.